Structural insights into ISRIB, a memory‐enhancing inhibitor of the integrated stress response

Citations Over TimeTop 17% of 2019 papers

Abstract

The integrated stress response (ISR) regulates protein synthesis under conditions of stress. Phosphorylation of translation initiation factor eIF2 by stress-sensing kinases converts eIF2 from substrate to competitive inhibitor of its dedicated nucleotide exchange factor, eIF2B, arresting translation. A drug-like molecule called integrated stress response inhibitor (ISRIB) reverses the effects of eIF2 phosphorylation and restores translation by targeting eIF2B. When administered to mice, ISRIB enhances cognition and limits cognitive decline due to brain injury. To determine ISRIB's mechanism of action, we solved an atomic structure of ISRIB bound to the human eIF2B decamer. We found that ISRIB acts as a molecular staple, pinning together tetrameric subcomplexes of eIF2B along the assembly path to a fully active, decameric enzyme. In this Structural Snapshot, we discuss ISRIB's mechanism, its ability to rescue disease mutations in eIF2B and conservation of the enzyme and ISRIB-binding pocket.

Related Papers

• → Structural basis for eIF2B inhibition in integrated stress response(2019)132 cited
• → Structure–Activity Studies of Bis‐O‐Arylglycolamides: Inhibitors of the Integrated Stress Response(2016)20 cited
• → Roles of mammalian sterile 20‐like kinase 2‐dependent phosphorylations of Mps one binder 1B in the activation of nuclear Dbf2‐related kinases(2009)21 cited
• → c-Myc transactivation domain-associated kinases: Questionable role for map kinases in c-Myc phosphorylation(1999)26 cited
• Identification and characterization of the nucleotide exchange factor eIF2B as the target of a memory-enhancing inhibitor of the integrated stress response(2018)